Natera Total Assets 2014-2023 | NTRA
Natera total assets from 2014 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Natera total assets for the quarter ending December 31, 2023 were $1.442B, a 3.39% increase year-over-year.
- Natera total assets for 2023 were $1.442B, a 3.39% increase from 2022.
- Natera total assets for 2022 were $1.394B, a 12.78% increase from 2021.
- Natera total assets for 2021 were $1.236B, a 32.65% increase from 2020.
| Natera Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $1,442 |
| 2022 | $1,394 |
| 2021 | $1,236 |
| 2020 | $932 |
| 2019 | $583 |
| 2018 | $268 |
| 2017 | $215 |
| 2016 | $211 |
| 2015 | $265 |
| 2014 | $124 |
| 2013 | $60 |
| Natera Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,442 |
| 2023-09-30 | $1,447 |
| 2023-06-30 | $1,248 |
| 2023-03-31 | $1,319 |
| 2022-12-31 | $1,394 |
| 2022-09-30 | $1,009 |
| 2022-06-30 | $1,067 |
| 2022-03-31 | $1,145 |
| 2021-12-31 | $1,236 |
| 2021-09-30 | $1,311 |
| 2021-06-30 | $850 |
| 2021-03-31 | $894 |
| 2020-12-31 | $932 |
| 2020-09-30 | $977 |
| 2020-06-30 | $723 |
| 2020-03-31 | $559 |
| 2019-12-31 | $583 |
| 2019-09-30 | $380 |
| 2019-06-30 | $383 |
| 2019-03-31 | $261 |
| 2018-12-31 | $268 |
| 2018-09-30 | $277 |
| 2018-06-30 | $194 |
| 2018-03-31 | $219 |
| 2017-12-31 | $215 |
| 2017-09-30 | $204 |
| 2017-06-30 | $158 |
| 2017-03-31 | $176 |
| 2016-12-31 | $211 |
| 2016-09-30 | $242 |
| 2016-06-30 | $261 |
| 2016-03-31 | $266 |
| 2015-12-31 | $265 |
| 2015-09-30 | $262 |
| 2015-06-30 | $107 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.994B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.860B | 15.54 |
| Cencora (COR) | United States | $47.415B | 18.92 |
| ICON (ICLR) | Ireland | $25.281B | 24.93 |
| DiDi Global (DIDIY) | China | $23.464B | 0.00 |
| Avantor (AVTR) | United States | $17.398B | 23.97 |
| CochLear (CHEOY) | $13.726B | 0.00 | |
| Viatris (VTRS) | United States | $13.628B | 3.89 |
| Revvity (RVTY) | United States | $12.785B | 22.26 |
| Medpace Holdings (MEDP) | United States | $12.615B | 41.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.511B | 0.00 |
| Charles River Laboratories (CRL) | United States | $12.369B | 22.55 |
| Solventum (SOLV) | United States | $10.955B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.218B | 20.07 |
| Organon (OGN) | United States | $4.734B | 4.58 |
| Doximity (DOCS) | United States | $4.585B | 34.14 |
| PACS (PACS) | United States | $3.659B | 0.00 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| Surgery Partners (SGRY) | United States | $3.213B | 29.86 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Premier (PINC) | United States | $2.520B | 9.22 |
| Teladoc Health (TDOC) | United States | $2.326B | 0.00 |
| Agilon Health (AGL) | United States | $2.195B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.166B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.832B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.364B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.790B | 8.17 |
| Embecta (EMBC) | United States | $0.626B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.440B | 0.00 |
| CareDx (CDNA) | United States | $0.426B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.397B | 0.00 |
| DocGo (DCGO) | United States | $0.365B | 58.33 |
| MultiPlan (MPLN) | United States | $0.361B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.323B | 0.00 |
| ModivCare (MODV) | United States | $0.320B | 4.24 |
| GeneDx Holdings (WGS) | United States | $0.313B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.285B | 0.00 |
| Sharecare (SHCR) | United States | $0.262B | 0.00 |
| Biodesix (BDSX) | United States | $0.124B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |